Mad in America

JANUARY 25, 2024

The study, titled “Estimating the smallest worthwhile difference of antidepressants: a cross-sectional survey,” delves into the challenging decisions faced by individuals considering SSRI and SNRI antidepressants, which are common treatments for depression. Only a third of patients are satisfied with these medications.

Depression treatment 142

Depression treatment 142

Mad in America

DECEMBER 25, 2023

In a study of fluoxetine (Prozac) for adolescents, researchers found that the placebo effect predicted good outcomes, but the actual drug treatment did not. After accounting for “treatment guess” (those who figured out that they were receiving an intervention rather than placebo), the drug was not effective in depression treatment.

Cognitive Behavioral Therapy 145

Cognitive Behavioral Therapy Depression treatment 145

Mad in America

DECEMBER 11, 2023

Take, for instance, a recent meta-analysis finding that exercise is just as good as antidepressants at treating mild to moderate depression —and that adding drugs to the regimen does not improve outcomes.

Poverty and mental health 145

Poverty and mental health Cognitive Behavioral Therapy Depression treatment Hospitality 145

Mad in America

JANUARY 3, 2024

However, there was recognition within the NIMH that that the industry-funded trials didn’t necessarily provide evidence of the efficacy of antidepressants in real-world patients, which prompted it to launch the STAR*D study, touting it as the “largest and longest study ever done to evaluate depression treatment.”

Neurotransmitters and mental health 144

Neurotransmitters and mental health Hospitality Education Self-awareness 144

Mad in America

JUNE 20, 2024

It is undeniable that it has been helpful for the pharmaceutical industry, which continues to grow yearly, and as of 2022, the antidepressant market has reached $17.02 The eighties and nineties were a depression-treatment renaissance. The same authors updated this study in 2022 where they examined another thirty drug trials.

Pharmaceuticals 139

Pharmaceuticals Manufacturing Construction Depression treatment 139

Mad in America

NOVEMBER 6, 2023

667 In an NIMH study of 547 patients that compared six-year outcomes for depressed people treated for the disorder and those who eschewed medical treatment, the treated patients were three times more likely than untreated ones to suffer a cessation of their principal social role and nearly seven times more likely to become incapacitated.

Bipolar disorder 145

Bipolar disorder Neurotransmitters and mental health Genetics and mental health Pharmaceuticals 145